{"url":"https://lda.senate.gov/api/v1/filings/a3040706-fb9c-4e7f-83f2-e32c25344499/","filing_uuid":"a3040706-fb9c-4e7f-83f2-e32c25344499","filing_type":"RR","filing_type_display":"Registration","filing_year":2025,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a3040706-fb9c-4e7f-83f2-e32c25344499/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Borden","dt_posted":"2025-07-14T18:12:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1501 K Street","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":35230,"url":"https://lda.senate.gov/api/v1/registrants/35230/","house_registrant_id":31204,"name":"SIDLEY AUSTIN LLP","description":"law firm","address_1":"1501 K Street","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KYLE J. FIET","contact_telephone":"+1 202-736-8446","dt_updated":"2026-07-23T11:09:46.010671-04:00"},"client":{"id":67723,"url":"https://lda.senate.gov/api/v1/clients/67723/","client_id":67723,"name":"ANNEXON BIOSCIENCES","general_description":"Pharmaceutical manufacturer","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-05-28"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Rare disease policy, drug approval process","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":147219,"prefix":"ms","prefix_display":"MS.","first_name":"PATRICIA","nickname":null,"middle_name":"LOUISE","last_name":"DELOATCHE","suffix":null,"suffix_display":null},"covered_position":"Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}